Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Puregene AG currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner, KEITH RICHARD WILLIAMS, and 1 distinct art unit. KEITH RICHARD WILLIAMS is the busiest examiner for the portfolio, handling 1 pending office action.
The 1 pending office action is the only active matter for the company at this time. Because it is assigned to 1 distinct examiner, the prosecution team can tailor its approach to the specific habits of KEITH RICHARD WILLIAMS. The 1 distinct art unit suggests that the technical subject matter is focused within a single specialized group. This concentration in the Biotechnology & Pharmaceuticals area allows for a direct line of communication with the USPTO.
With 1 distinct examiner and 1 distinct art unit, the portfolio lacks the complexity of multi-examiner coordination. The 1 pending office action represents the full scope of the company's current legal challenges in patent procurement. Practitioners should note that KEITH RICHARD WILLIAMS is the sole individual responsible for the examination of this portfolio. The 1 distinct art unit provides a stable environment for resolving the pending matter.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WILLIAMS, KEITH RICHARD | 1 | 50.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19142062 | QUANTITATIVE TRAIT LOCI ASSOCIATED WITH FLOWER TO LEAF RATIO IN CANNABIS | WILLIAMS, KEITH RICHARD | — |
| Art Unit | Apps |
|---|---|
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19142062 | QUANTITATIVE TRAIT LOCI ASSOCIATED WITH FLOWER TO LEAF RATIO IN CANNABIS | WILLIAMS, KEITH RICHARD | 1663 | §101§102§112 | Non-Final OA | — | Pending | Jun 20, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial